Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Gadolinium-based contrast agents (GBCAs) are widely used to enhance tissue contrast during MRI scans and play a crucial role in the management of patients with cancer. However, studies have shown gadolinium deposition in the brain after repeated GBCA administration with yet unknown clinical significance. We aimed to assess the feasibility and diagnostic value of synthetic post-contrast T1-weighted MRI generated from pre-contrast MRI sequences through deep convolutional neural networks (dCNN) for tumour response assessment in neuro-oncology. METHODS: In this multicentre, retrospective cohort study, we used MRI examinations to train and validate a dCNN for synthesising post-contrast T1-weighted sequences from pre-contrast T1-weighted, T2-weighted, and fluid-attenuated inversion recovery sequences. We used MRI scans with availability of these sequences from 775 patients with glioblastoma treated at Heidelberg University Hospital, Heidelberg, Germany (775 MRI examinations); 260 patients who participated in the phase 2 CORE trial (1083 MRI examinations, 59 institutions); and 505 patients who participated in the phase 3 CENTRIC trial (3147 MRI examinations, 149 institutions). Separate training runs to rank the importance of individual sequences and (for a subset) diffusion-weighted imaging were conducted. Independent testing was performed on MRI data from the phase 2 and phase 3 EORTC-26101 trial (521 patients, 1924 MRI examinations, 32 institutions). The similarity between synthetic and true contrast enhancement on post-contrast T1-weighted MRI was quantified using the structural similarity index measure (SSIM). Automated tumour segmentation and volumetric tumour response assessment based on synthetic versus true post-contrast T1-weighted sequences was performed in the EORTC-26101 trial and agreement was assessed with Kaplan-Meier plots. FINDINGS: (-0·37 to -0·76) with the concordance correlation coefficient suggesting a strong linear association between tumour volumes derived from synthetic versus true post-contrast T1-weighted sequences (0·782, 0·751-0·807, p<0·0001). Volumetric tumour response assessment in the EORTC-26101 trial showed a median time to progression of 4·2 months (95% CI 4·1-5·2) with synthetic post-contrast T1-weighted and 4·3 months (4·1-5·5) with true post-contrast T1-weighted sequences (p=0·33). The strength of the association between the time to progression as a surrogate endpoint for predicting the patients' overall survival in the EORTC-26101 cohort was similar when derived from synthetic post-contrast T1-weighted sequences (hazard ratio of 1·749, 95% CI 1·282-2·387, p=0·0004) and model C-index (0·667, 0·622-0·708) versus true post-contrast T1-weighted MRI (1·799, 95% CI 1·314-2·464, p=0·0003) and model C-index (0·673, 95% CI 0·626-0·711). INTERPRETATION: Generating synthetic post-contrast T1-weighted MRI from pre-contrast MRI using dCNN is feasible and quantification of the contrast-enhancing tumour burden from synthetic post-contrast T1-weighted MRI allows assessment of the patient's response to treatment with no significant difference by comparison with true post-contrast T1-weighted sequences with administration of GBCAs. This finding could guide the application of dCNN in radiology to potentially reduce the necessity of GBCA administration. FUNDING: Deutsche Forschungsgemeinschaft.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Image quality assessment: from error visibility to structural similarity
Wang, Z., Bovik, A. C., Sheikh, H. R., & Simoncelli, E. P. (2004) · IEEE Transactions on Image Processing · doi:10.1109/tip.2003.819861 · Cited by 57,892
Checklist for Artificial Intelligence in Medical Imaging (CLAIM): a guide for authors and reviewers
Mongan, J., Moy, L., & Kahn, C. E. (2020) · Radiology: Artificial Intelligence · doi:10.1148/ryai.2020200029 · Cited by 1,443
A Review on Generative Adversarial Networks: Algorithms, Theory, and Applications
Gui, J., Sun, Z., Wen, Y., Tao, D., & Ye, J. (2023) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2021.3130191 · Cited by 1,231
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Self-citationDeep learning enables reduced gadolinium dose for contrast-enhanced brain MRI
Gong, E., Pauly, J. M., Wintermark, M., & Zaharchuk, G. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25970 · Cited by 351
Cited by
Large-scale pancreatic cancer detection via non-contrast CT and deep learning
Cao, K., Xia, Y., Yao, J., Han, X., Lambert, L., Zhang, T., Tang, W., Jin, G., Jiang, H., Fang, X., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02640-w · Cited by 358
“Unlike generative deep learning methods to synthesize contrast or color 18–21 , we train supervised learning models, which effectively capture subtle image details and directly learn downstream lesion detection and diagnosis tasks based on these detailed characteristics.”
Pflüger, I., Wald, T., Isensee, F., Schell, M., Meredig, H., Schlamp, K., Bernhardt, D., Brugnara, G., Heußel, C. P., Debus, J., et al. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac138 · Cited by 31
Self-citationHussein, R., Shin, D., Zhao, M. Y., Guo, J., Davidzon, G., Steinberg, G., Moseley, M., & Zaharchuk, G. (2024) · Medical Image Analysis · doi:10.1016/j.media.2023.103072 · Cited by 9
Metadata
- Authors
- Jayachandran Preetha, C., Meredig, H., Brugnara, G., Mahmutoglu, M. A., Foltyn, M., Isensee, F., Kessler, T., Pflüger, I., Schell, M., Neuberger, U., Petersen, J., Wick, A., Heiland, S., Debus, J., Platten, M., Idbaih, A., Brandes, A. A., Winkler, F., van den Bent, M. J., Nabors, B., Stupp, R., Maier-Hein, K. H., Gorlia, T., Tonn, J.-C., Weller, M., Wick, W., Bendszus, M., & Vollmuth, P.
- Venue
- The Lancet Digital Health
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 3
- Issue
- 12
- Pages
- e784-e794
- ISSN
- 2589-7500 (ISSN-L)
- OpenAlex
- W3205881285
- Cited by
- 122
- References
- 5
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study. https://app.cochat.ai/papers/10.1016/s2589-7500(21)00205-3
- The paper
- Jayachandran Preetha, C., Meredig, H., Brugnara, G., Mahmutoglu, M. A., Foltyn, M., Isensee, F., Kessler, T., Pflüger, I., Schell, M., Neuberger, U., Petersen, J., Wick, A., Heiland, S., Debus, J., Platten, M., Idbaih, A., Brandes, A. A., Winkler, F., van den Bent, M. J., . . . Vollmuth, P. (2021). Deep-learning-based synthesis of post-contrast T1-weighted MRI for tumour response assessment in neuro-oncology: a multicentre, retrospective cohort study. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(21)00205-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.